![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208555
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-13-2023-38736.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-second-phase-iii-study-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-and-presents-consistent-and-predictable-pk-results-across-multiple-surgeries-301841948.html
https://www.prnewswire.com/news-releases/cali-biosciences-initiates-phase-iii-studies-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-301801255.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-5-2023-55870.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210102
https://www.prnewswire.com/news-releases/cali-biosciences-announces-successful-results-in-phase-iib-study-of-long-acting-ropivacaine-cpl-01-for-non-opioid-treatment-of-post-operative-pain-301505715.html
https://www.asiaone.com/business/asra-2021-cali-biosciences-presents-phase-iia-clinical-data-cpl-01-long-acting-ropivacaine
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214074
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-1-2020-1593586904.pdf
https://www.pharmacompass.com/pdf/news/fresenius-kabis-recall-of-ketorolac-results-in-quva-pharma-recall-of-compounded-sterile-product-reck-1588048740.pdf
https://www.pharmacompass.com/pdf/news/pharmedium-services-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-sterile-products-1587014091.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212808
https://www.biospectrumasia.com/news/25/14766/tlc-announces-completion-of-27-m-financing.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-26-2018-1545811500.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210102
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-15-2018-1534336681.pdf
https://www.pharmacompass.com/pdf/news/naropin-ropivacaine-hydrochloride-fresenius-kabi-usa-v-custopharm-inc-1533729310.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206166
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204636
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2017-1499837241.pdf
https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-ropivacaine-hydrochloride-approved-in-usa-1468664522.pdf
https://www.pharmacompass.com/pdf/news/akorn-incs-generic-ropivacaine-hydrochloride-approved-in-us-as-anesthesia-1460633015.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-inks-pact-with-us-firm-for-ropivacaine-infusion-system/articleshow/50467682.cms